Ledger.Open graph →
SEC Form D · filed August 16, 2022

Bluejay Therapeutics, Inc

Offering
$41.2M
Sold
$20.5M
Exemption
Rule 506(b)
Industry
Other Technology
Location
San Mateo, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Nancy M. Hong · St. Louis, MODirectorTing J. Jia · New York, NYDirectorVivjan M. Myrto · Boston, MADirectorKeting Chu · Hong Kong, Hong KongExec · DirectorDajun Yang · Rockville, MDDirectorAlon Lazarus · Cambridge, MADirectorWilliam J. Rutter · Norwood, MADirectorWen Chen · CAMBRIDGE, MADirectorKaren S. Dyczkowski · Vancouver, British Columbia, CanadaDirectorKeting Chu · Hong Kong, Hong KongExec · DirectorDajun Yang · Rockville, MDDirectorAlon Lazarus · Cambridge, MADirectorWilliam J. Rutter · San Francisco, CADirectorTing J. Jia · New York, NYDirectorWen Chen · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗